Pierre Johansen

714 total citations
43 papers, 543 citations indexed

About

Pierre Johansen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Pierre Johansen has authored 43 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Pierre Johansen's work include Diabetes Treatment and Management (28 papers), Diabetes Management and Research (17 papers) and Metabolism, Diabetes, and Cancer (13 papers). Pierre Johansen is often cited by papers focused on Diabetes Treatment and Management (28 papers), Diabetes Management and Research (17 papers) and Metabolism, Diabetes, and Cancer (13 papers). Pierre Johansen collaborates with scholars based in Denmark, United States and Sweden. Pierre Johansen's co-authors include Michael Willis, Barnaby Hunt, C. Neslusan, Samuel J. P. Malkin, Emelie Andersson, Katarina Steen Carlsson, Matthew Capehorn, Anna Sandberg, João Fernandes and Adam Lundqvist and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Pierre Johansen

42 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Johansen Denmark 15 396 162 140 92 70 43 543
Alain Gay Germany 11 183 0.5× 54 0.3× 25 0.2× 89 1.0× 61 0.9× 22 369
Devin Abrahami Canada 12 141 0.4× 94 0.6× 69 0.5× 172 1.9× 88 1.3× 22 423
Tom Manley United States 5 269 0.7× 84 0.5× 37 0.3× 113 1.2× 61 0.9× 6 509
Jin Choi United States 10 93 0.2× 32 0.2× 40 0.3× 130 1.4× 34 0.5× 19 359
Lluís Vila Spain 12 228 0.6× 38 0.2× 55 0.4× 42 0.5× 15 0.2× 42 393
Elizabeth Kern United States 9 90 0.2× 71 0.4× 67 0.5× 44 0.5× 45 0.6× 11 450
Guillermo González-Gálvez Mexico 13 811 2.0× 266 1.6× 55 0.4× 286 3.1× 27 0.4× 30 887
Radhika Rajgopal Singh United States 4 181 0.5× 47 0.3× 68 0.5× 82 0.9× 33 0.5× 5 448
Yuan-Lin Guo China 13 109 0.3× 28 0.2× 73 0.5× 203 2.2× 57 0.8× 20 373
Olga Montvida Australia 12 403 1.0× 123 0.8× 91 0.7× 97 1.1× 24 0.3× 31 557

Countries citing papers authored by Pierre Johansen

Since Specialization
Citations

This map shows the geographic impact of Pierre Johansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Johansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Johansen more than expected).

Fields of papers citing papers by Pierre Johansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Johansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Johansen. The network helps show where Pierre Johansen may publish in the future.

Co-authorship network of co-authors of Pierre Johansen

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Johansen. A scholar is included among the top collaborators of Pierre Johansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Johansen. Pierre Johansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Younossi, Zobair M., et al.. (2022). The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes. JHEP Reports. 4(9). 100525–100525. 63 indexed citations
3.
Bøgelund, Mette, et al.. (2022). The prevalence of comorbidities in Danish patients with obesity – A Danish register‐based study based on data from 2002 to 2018. Clinical Obesity. 12(5). e12542–e12542. 8 indexed citations
4.
Bøgelund, Mette, et al.. (2022). The substantial costs to society associated with obesity – a Danish register-based study based on 2002-2018 data. Expert Review of Pharmacoeconomics & Outcomes Research. 22(5). 823–833. 4 indexed citations
5.
Tapper, Elliot B., et al.. (2022). The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies. SHILAP Revista de lepidopterología. 1(6). 1049–1087. 3 indexed citations
6.
7.
Yamada, T., Nobuhiro Shojima, Toshimasa Yamauchi, et al.. (2019). Clinical care and other categories posters: Incretin therapies. Diabetic Medicine. 36(S1). 134–135. 1 indexed citations
8.
Johansen, Pierre, Barnaby Hunt, Neeraj N. Iyer, Tam Dang‐Tan, & Richard F. Pollock. (2019). A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA. Advances in Therapy. 36(5). 1190–1199. 8 indexed citations
9.
10.
Wilkinson, Lars, Barnaby Hunt, Pierre Johansen, et al.. (2018). Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States. Diabetes Therapy. 9(3). 951–961. 16 indexed citations
11.
12.
13.
Neslusan, C., et al.. (2016). Cost-effectiveness of Canagliflozin versus Sitagliptin When Added to Metformin and Sulfonylurea in Type 2 Diabetes in Canada.. PubMed. 23(2). e151–68. 16 indexed citations
14.
15.
16.
Neslusan, C., et al.. (2015). Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus in Mexico. Value in Health Regional Issues. 8. 8–19. 16 indexed citations
17.
18.
19.
Lundqvist, Adam, Katarina Steen Carlsson, Pierre Johansen, Emelie Andersson, & Michael Willis. (2014). Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations. PLoS ONE. 9(10). e110235–e110235. 47 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alain Gay Breakdown of academic impact, for papers by Devin Abrahami Breakdown of academic impact, for papers by Tom Manley Breakdown of academic impact, for papers by Jin Choi Breakdown of academic impact, for papers by Lluís Vila Breakdown of academic impact, for papers by Elizabeth Kern Breakdown of academic impact, for papers by Guillermo González-Gálvez Breakdown of academic impact, for papers by Radhika Rajgopal Singh Breakdown of academic impact, for papers by Yuan-Lin Guo Breakdown of academic impact, for papers by Olga Montvida
Rankless by CCL
2026